Speaker Profile
Ph.D., Clinical Science Lead, Digital Biomarkers, Verily
Biography
Sooyoon Shin, PhD, is the Clinical Science Lead for the Digital Biomarkers team at Verily, where she leads the research and evidence generation for digital measures. She oversees the development, validation, and implementation of these measures in both internal and external clinical studies, driving cross-functional collaboration. With over two decades of expertise in neuroscience, data science and clinical science, she is committed to advancing clinical trials and patient care through patient-centric digital solutions.
Talk
Improving Clinical Trial Efficiency with Wearables in Parkinson's Trials
Wearable sensor technology enables capturing patient-centric digital measurements passively and continuously. Drug development for Parkinsons disease would benefit greatly from digital endpoints to replace the current, subjective, gold standard tests. We present a case study on Verilys Study Watch demonstrating high compliance throughout multi-year studies, and clinical validity for treatment response with passive measurements.
Digital Health Showcase:
Verily
Verily is an Alphabet health technology company focused on research, care, and public health to deliver on the promise of precision health.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Digital Health Showcase will provide 15-30 minute speaking opportunities for selected companies working with the latest technologies in precision medicine to highlight their contributions to the field.
